AINewsnow

MLIPDiff: Guiding Denoising Diffusion Models for Structure-Based Drug Design via Machine-Learned Interatomic Potentials

This story is from 2026-10-27. It is preserved in the archive; the latest stories are on the live feed.

arXiv:2610.33315v1 Announce Type: new Abstract: Diffusion models have become a dominant approach to structure-based drug design. However, because they are trained primarily to fit reference structures, they often place ligands in physically implausible poses that clash with the protein. We introduc…

Read the full story at arXiv cs.LG ↗

Timeline · 1 report

  1. 2026-10-27 04:00 · arXiv cs.LG
    MLIPDiff: Guiding Denoising Diffusion Models for Structure-Based Drug Design via Machine-Learned Interatomic Potentials

More stories

  1. DeepMind unveils Genie 4 world model promising more realistic physics and humans — Ars Technica AI
  2. Anthropic reveals plans for blockbuster IPO — Sky News Technology
  3. Elon Musk says more than 200 neoclouds face 'guppy-level death' — CNBC Technology
  4. Muse Is Now Available in Singapore: The World’s First Personal AI Agent Built for Everyone — Meta Newsroom
  5. Introducing GPT-6.1 Terra — OpenAI News
  6. Nvidia-Backed Firm Launches $3.1 Billion GPU Loan into Market — Bloomberg AI
  7. Microsoft to reportedly offer buyouts to 60,000 employees in latest cuts — The Guardian AI
  8. Apple Creator Studio update adds MotionVFX to Final Cut, and AI to everywhere — Engadget

Get the daily brief of stories like this at 6:30 every morning →